대원제약
003220KOSPI56.0 / 100
Reference Date: 2026-09-08
Company InformationBased on 2025 Annual Report
Business Overview
Daewon Pharmaceutical operates in pharmaceuticals, cosmetics, and health functional foods, focusing on CMO services, overseas exports, and the development of OTC drugs and health supplements. Key subsidiaries include Daewon Meditech (hearing aid sales), Daewon Pharmaceutical Vietnam (Southeast Asia market expansion), SD Biotech (cosmetics brand 'SNP'), and 'Ogam Shikdak' (a 2022-launched convenience food brand targeting online markets with products like 'Token Broth').
Number of Employees
1,349people
Average Salary
77.3M KRW
Score Calculation Basis
Detailed Financial Score
Lower than industry avg (good)
Well below industry avg
Half of industry avg (excellent)
Avg ▲7.4% (2-year basis)
Avg ▼50.1% (2-year basis)
Avg ROE 3.7% (declining, 3yr)
Detailed News Sentiment
- Positive대원헬스, 먹고 바르는 PDRN 듀얼 패키지 출시
대원헬스의 PDRN 듀얼 패키지 출시로 건강기능식품 시장에서의 경쟁력 강화 기대.
- Neutral[바이오스냅] 한미약품, 유럽서 고인슐린증 치료제 임상 발표
관련성 없음: 한미약품의 유럽 임상 발표는 대원제약과 직접적인 연관성이 없다.
- Neutral'약가인하 파고' 본업만으론 부족하다?화장품·건기식 키우는 제약사
제약사들이 화장품 및 건강기능식품 분야 확장으로 수익성 개선을 모색하고 있으나, 직접적인 영향은 제한적임.
Detailed Momentum
Near 52w low (12%, downtrend)
1m -1.96% (flat)
Volume surge
Detailed Disclosure
- Neutral공정거래자율준수프로그램운영현황(안내공시)2026-08-28
